These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


479 related items for PubMed ID: 27528407

  • 1. Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials.
    Li Y, Huang T, Zheng Y, Muka T, Troup J, Hu FB.
    J Am Heart Assoc; 2016 Aug 15; 5(8):. PubMed ID: 27528407
    [Abstract] [Full Text] [Related]

  • 2. Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: a meta-analysis of randomized controlled trials.
    Qin X, Huo Y, Xie D, Hou F, Xu X, Wang X.
    Clin Nutr; 2013 Oct 15; 32(5):722-7. PubMed ID: 23313356
    [Abstract] [Full Text] [Related]

  • 3. Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels.
    Miller ER, Juraschek S, Pastor-Barriuso R, Bazzano LA, Appel LJ, Guallar E.
    Am J Cardiol; 2010 Aug 15; 106(4):517-27. PubMed ID: 20691310
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials.
    Yang HT, Lee M, Hong KS, Ovbiagele B, Saver JL.
    Eur J Intern Med; 2012 Dec 15; 23(8):745-54. PubMed ID: 22884409
    [Abstract] [Full Text] [Related]

  • 5. Folic Acid Supplementation for Stroke Prevention in Patients With Cardiovascular Disease.
    Tian T, Yang KQ, Cui JG, Zhou LL, Zhou XL.
    Am J Med Sci; 2017 Oct 15; 354(4):379-387. PubMed ID: 29078842
    [Abstract] [Full Text] [Related]

  • 6. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials.
    Bazzano LA, Reynolds K, Holder KN, He J.
    JAMA; 2006 Dec 13; 296(22):2720-6. PubMed ID: 17164458
    [Abstract] [Full Text] [Related]

  • 7. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R, Armitage J.
    Semin Thromb Hemost; 2000 Dec 13; 26(3):341-8. PubMed ID: 11011852
    [Abstract] [Full Text] [Related]

  • 8. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis.
    Jardine MJ, Kang A, Zoungas S, Navaneethan SD, Ninomiya T, Nigwekar SU, Gallagher MP, Cass A, Strippoli G, Perkovic V.
    BMJ; 2012 Jun 13; 344():e3533. PubMed ID: 22695899
    [Abstract] [Full Text] [Related]

  • 9. Folic acid supplementation for stroke prevention: A systematic review and meta-analysis of 21 randomized clinical trials worldwide.
    Zhang N, Zhou Z, Chi X, Fan F, Li S, Song Y, Zhang Y, Qin X, Sun N, Wang X, Huo Y, Li J.
    Clin Nutr; 2024 Jul 13; 43(7):1706-1716. PubMed ID: 38824900
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis.
    Lee M, Hong KS, Chang SC, Saver JL.
    Stroke; 2010 Jun 13; 41(6):1205-12. PubMed ID: 20413740
    [Abstract] [Full Text] [Related]

  • 11. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.
    B-Vitamin Treatment Trialists' Collaboration.
    Am Heart J; 2006 Feb 13; 151(2):282-7. PubMed ID: 16442889
    [Abstract] [Full Text] [Related]

  • 12. The effect of folate fortification on folic acid-based homocysteine-lowering intervention and stroke risk: a meta-analysis.
    Zeng R, Xu CH, Xu YN, Wang YL, Wang M.
    Public Health Nutr; 2015 Jun 13; 18(8):1514-21. PubMed ID: 25323814
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of folic acid supplementation in stroke prevention: new insight from a meta-analysis.
    Huo Y, Qin X, Wang J, Sun N, Zeng Q, Xu X, Liu L, Xu X, Wang X.
    Int J Clin Pract; 2012 Jun 13; 66(6):544-51. PubMed ID: 22607506
    [Abstract] [Full Text] [Related]

  • 14. Homocysteine-lowering therapy does not lead to reduction in cardiovascular outcomes in chronic kidney disease patients: a meta-analysis of randomised, controlled trials.
    Pan Y, Guo LL, Cai LL, Zhu XJ, Shu JL, Liu XL, Jin HM.
    Br J Nutr; 2012 Aug 13; 108(3):400-7. PubMed ID: 22244447
    [Abstract] [Full Text] [Related]

  • 15. The current status of homocysteine as a risk factor for cardiovascular disease: a mini review.
    Chrysant SG, Chrysant GS.
    Expert Rev Cardiovasc Ther; 2018 Aug 13; 16(8):559-565. PubMed ID: 29979619
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis.
    Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, Sun N, Liu L, Xu X.
    Lancet; 2007 Jun 02; 369(9576):1876-1882. PubMed ID: 17544768
    [Abstract] [Full Text] [Related]

  • 17. Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
    Clarke R, Lewington S, Sherliker P, Armitage J.
    Curr Opin Clin Nutr Metab Care; 2007 Jan 02; 10(1):32-9. PubMed ID: 17143052
    [Abstract] [Full Text] [Related]

  • 18. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
    Booth GL, Wang EE.
    CMAJ; 2000 Jul 11; 163(1):21-9. PubMed ID: 10920726
    [Abstract] [Full Text] [Related]

  • 19. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.
    Morgan SL, Baggott JE, Lee JY, Alarcón GS.
    J Rheumatol; 1998 Mar 11; 25(3):441-6. PubMed ID: 9517760
    [Abstract] [Full Text] [Related]

  • 20. Effect of folic acid supplementation on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials.
    Qin X, Xu M, Zhang Y, Li J, Xu X, Wang X, Xu X, Huo Y.
    Atherosclerosis; 2012 Jun 11; 222(2):307-13. PubMed ID: 22209480
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.